Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
Article in EClinicalMedicine (February 2024)
The most recent citing publications are shown below. View all 92 publications that cite this research output on Dimensions.
Article in EClinicalMedicine (February 2024)
Article in Annals of Behavioral Medicine (January 2024)
Article in Studies in Ethnicity and Nationalism (January 2024)